Kraft Heinz to remove artificial dyes from food products
Digest more
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.
The U.S. Food and Drug Administration said on Tuesday it is launching a program under which its commissioner can issue vouchers to companies to shorten their review time for a drug application to 1-2 months from the typical timeline of about 10-12 months.
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one to two months for companies it says are backing national interests.
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions align with the FDA's national health priorities.
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and "unleash AI."
A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic mushrooms” — helped with depression